Specialized Technology Education for Pumps & Pens in Underserved Populations With Diabetes

NCT04550585 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 63

Last updated 2023-04-24

No results posted yet for this study

Summary

Lower socioeconomic status (SES) individuals with type 1 diabetes have poorer outcomes than wealthier patients and part of this disparity comes from a lack of tools and knowledge about how to teach these patients on the technologies other patients take for granted. Therefore, this is a study designed to develop and test low literacy English/Spanish language teaching tools for patients with type 1 diabetes treated with varying types of technology in the Los Angeles County healthcare system. The aims are to:To reduce health disparities for underserved adults with diabetes on multiple daily injection (MDI) therapy using vials and syringes through the use of a simplified lower literacy, culturally and language appropriate approach to teach, implement and follow these individuals started on insulin pens and pumps/continuous subcutaneous insulin infusion (CSII); To show no increase in rates of diabetic ketoacidosis (DKA) or severe hypoglycemia when using CSII or pen therapy compared to baseline rates; To reduce time spent in hyper and hypoglycemic ranges, as well as glycemic variability, as measured by blinded continuous glucose monitoring (CGM); Reduce psychological distress due to diabetes and improve health-related quality of life, as measured by validated distress and quality of life scales. Secondary Aims include: Reduction in A1C levels with CSII/pen therapy compared to standard MDI treatment; and to perform a cost-analysis of the process of implementation to improve the generalizability of the model.

Conditions

  • Type1diabetes

Interventions

OTHER

Education: Session 1 - Basics of type 1 management

In a group education session, a diabetes educator provides educational session 1 - Basics of type 1 management. Accompanying educational guide: How Can I Manage My Type 1 Diabetes Better?

OTHER

Session 2 - Carbohydrate counting

In a group education session, a diabetes educator provides educational session 2 - Carbohydrate counting Accompanying educational guide: How Can I Manage My Type 1 Diabetes Better?

OTHER

Education: Session 3 - Insulin self- adjustment

In a group education session, a diabetes educator provides educational session 3 - Insulin self- adjustment Accompanying educational guide: How Can I Manage My Type 1 Diabetes Better?

OTHER

Education: Session 4 - Sick day rules and physical activity dose adjustments

In a group education session, a diabetes educator provides educational session 4 - Sick day rules and physical activity dose adjustments Accompanying educational guide: How Can I Manage My Type 1 Diabetes Better?

OTHER

Education: Session 5 - Starting the insulin pen (for pen users) or pump (for pump users)

In a group education session, a diabetes educator provides educational session 5 - Starting the insulin pen (for pen users) or pump (for pump users) Accompanying educational guide: Is the Insulin Pump Right for Me? How Do I Use an Insulin Pump? Is the Insulin Pen Right for Me?

OTHER

Education: Session 6 - Trouble shooting the pump (for pump users)

In a group education session, a diabetes educator provides educational session 6 - Trouble shooting the pump (for pump users) Accompanying educational guide: Is the Insulin Pump Right for Me? How Do I Use an Insulin Pump?

Sponsors & Collaborators

  • The Leona M. and Harry B. Helmsley Charitable Trust

    collaborator OTHER
  • University of Southern California

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-01
Primary Completion
2019-10-31
Completion
2020-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04550585 on ClinicalTrials.gov